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1. Introduction 
Avilamycin, a chlorine-containing antibiotic pro- 
duced by Streptomyces viridochromogenes, primarily 
inhibits the growth of Gram-positive bacteria. Isolation 
and characterization have been described [2]. The 
structure of avilamycin, a polysaccharide antibiotic 
bearing a curacin end group, is similar to that of 
curamycin and the everninomycins [2, 31. However, 
nothing is known about the mode of action of these 
compounds. 
This paper describes the effects of avilamycin on 
the protein and nucleic acid synthesis in Bacillus 
brevis cells, as well as on the polypeptide synthesis in 
the cell-free systems of B. brevis and E. coli. 
2. Materials and methods 
2.1. Materials 
Ribosomes, 30 S and 50 S ribosomal subunits, and 
supernatant enzymes (S-100 fraction ) from E. coli 
Al9 [4], a RNAase I-less mutant, and B. brevis 
ATCC 9999 were prepared as described [5]. After 
high-speed centrifugation, a fraction of supematant 
fluid was dialyzed with 10 mM Tris-HCl buffer pH 7.6 
containing 10 mM magnesium acetate and 6 mM 
2-mercaptoethanol. The ribosomes were suspended in 
10 mM magnesium acetate, the ribosomal subunits 
however, in 1 mM magnesium acetate. All collected 
enzymes and ribosomal particles were kept until use 
at -65°C (see sect. 2.2). 
* Metabolic products of microorganisms, 121; for preceding 
publication see [ 11. 
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Formyl- [3H] methionyl-tRNA was prepared from 
E. coli MRE 600 tRNA (Boehringer, Mannheim) and 
[ 3H] methionine according to the procedure of Hershey 
and Thach [6]. Crude initiation factors were isolated 
as described [7]. 
[3H] methionine (9 Ci/mM), [ 14C] isoleucine 
(10 mCi/mM), and [ 14C] phenylalanine (492 mCi/mM) 
were purchased from the Radiochemical Centre, 
Amersham, [ 14C] phenylalanyl-t RNA, 0.134 &i/mg) 
from the New England Nuclear Corporation, and 
[3H]poly U (81.6 I.tCi/pMP) from the Miles Laboratories 
Crystalline avilamycin was isolated as described [2]. 
2.2. Protein synthesis 
Experiments for polyphenylalanine synthesis were 
carried out by a method similar to that of Traub et al. 
[8]. Each incubation mixture (50 ~1) contained: 10 
10 mM Tris-HCl pH 7.8; 30 mM NH4C1; 10 mM 
magnesium acetate, 6 mM 2-mercaptoethanol; 1 mM 
ATP; 0.03 mM GTP; 0.05 mM 19 amino acids except 
phenylalanine; 5 mM phosphoenolpyruvic acid; 1 E.cg 
pyruvate kinase; 0.02 @i [ 14C] phenylalanine; 10 pg 
poly U; 5 FL enzyme fraction (S-100); 0.2 A260 unit 
of 70 S ribosomes or 50 S and 30 S ribosomal subunits 
and 1 ~1 of antibiotic solution (avilamycin was 
dissolved in ethanol). 
The reaction mixture was incubated for 45 min at 
30°C. The incorporation of radioactivity into hot 5% 
trichloroacetic acid-precipitable material was measured 
by assaying a sample (40 ~1) of the reaction mixture 
by the paper disk method [9]. 
The assay for protein synthesis directed by natural 
mRNA was performed using the same reaction mix- 
ture as that described above, except that poiy U is 
replaced by Q/3 RNA (Miles Laboratories). The incuba- 
tion mixture also contained 0.5 pg leucovorin. 
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2.3. Determination of aminoacyl-tRNA binding to Table 1 
ribosomal particles 
The binding of [ 14C]phenylalanyl-tRNA to ribo- 
somes was assayed as described [lo]. Fifty ~1 binding 
buffer (100 mM Tris-acetate, pH 7.2, 20 mM magne- 
sium acetate, 50 mM KCl) contained 2 AZ,, units of 
washed ribosomes, 20 pg poly U, and 0.01 /.Ei [ 14C]- 
phenylalanyl-tRNA. 
Effect of avilamycin on the formation of [ 14C] phenylalanyl- 
tRNA (15 coli). 
Avilamycin added [ 14C] phenylalanyl- Synthesized 
W) tRNA (cpm) W) 
The reaction mixture (50 ~1) for enzymatic binding 
of formyl- [3H] methionyl-tRNA to 30 S ribosomal 
subunits was similar to that of Hershey et al. [7]: 
50 mM Tris-HCl pH 7.4; 100 mM NH4C1; 5 mM 
magnesium acetate; 6 mM 2-mercaptoethanol; 1 mM 
GTP; 0.2 mM AUG (Boehringer, Mannheim); 0.02 PCi 
formyl-[3H]methionyl-tRNA, 1 A,,, unit of 30 8 
ribosomal subunits, and 20 pg crude initiation factors. 
Control 2 930 100 
1.43 x10-6 2 880 98 
1.43 x10-s 2 810 96 
1.43 x 10-4 2 800 96 
The assay was performed using the incubation mixture for 
polyphenylalanine synthesis without ribosomal particles. The 
incorporation of radioactivity into cold 5% trichloroacetic 
acid-precipitate material was measured. 
The reaction mixture was incubated for 15 min at 
24°C than diluted by addition of 3 ml of ice-cold 
binding buffer, and filtered through a Millipore filter 
(HA 0.45 /*m pore size). The filter was dried, and the 
radioactivity measured. 
1.43 X 1 0p5 M of avilamycin, while partial inhibition 
was observed, when the same incorporation system 
was used, except that the natural mRNA was replaced 
by poly U (fig. 2). These results suggest hat avila- 
mycin mainly interferes with the formation of the 
initiation complex. 
3. Results and discussion 
In a further experiment the effect of avilamycin on 
the formation of [ 14C] phenylalanyl-tRNA was 
examined. As shown in table 1, this reaction was not 
at all affected by the antibiotic. The attachment of 
The effect of avilamycin on the incorporation of 
[ 14C] thymidine, [ 14C] uracil, and [ 14C] isoleucine by 
intact cells of B. brevis was determined. Avilamycin 
inhibited isoleucine incorporation within less than 
3 min after addition, whereas the rate of thymidine 
and uracil incorporation remained essentially unchanged 
for 30 min after addition of the antibiotic (fig. 1). We 
inferred from these data that avilamycin acts as a 
specific inhibitor of protein synthesis in B. brevis 
cells. This conclusion was further substantiated by 
in vitro experiments. 
Table 2 
Effect of avilamycin on poly U-directed incorporation of 
[ 14C]isoleucine (E. coli). 
Antibiotic added 
W) 
As shown in fig. 2, avilamycin inhibited the poly 
U-directed polyphenylalanine synthesis in the in vitro 
system of B. brevis to the extent of approximately 
68%. 
Peptide synthesis in the in vitro system of E. coli 
was also inhibited, whereas the inhibition of growing 
cells was not observed (fig. 2). Thus the difference in 
susceptibility of B. brevis and E. coli may be due to 
a difference in factors other than those contained in 
the protein-synthesizing system. 
Control 
Avilamycin 
1.43 x 10-7 
1.43 x10-6 
1.43 x10-s 
1.43 x 10-4 
Streptomycin 
1.37 x 10-7 
1.37 x10-6 
1.37 x10-s 
1.37 x 10-4 
When the protein synthesis was directed by natural 
mRNA, complete inhibition was observed with 
The samples contained the standard reaction mixture except 
that 0.01 PCi [ 14C]isoleucine was substituted for [ 14C]- 
phenylalanine. 
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Polyisoleucine 
synthesized 
(cpm) 
80 
32 
26 
30 
18 
465 
436 
333 
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TIME (min) 
TIME (min) 
[ 3H] poly U to ribosomes was studied in the presence 
and absence of avilamycin by zone sedimentation on 
linear density gradients. Messenger RNA bound to 
ribosomes sediments more rapidly than free mRNA 
and is found in the gradient at a position close to that 
of the particle to which it is attached. The data of 
these binding studies indicated that avilamycin did 
not change the binding capacity of ribosomes to 
poly u (fig. 3). 
Avilamycin was also tested in an assay system, where 
0 20 40 60 
TIME (mlr) 
Fig. 1. Effect of avilamycin on the incorporation of a) [ 14C]- 
thymidine, b) [ t4C]uracil, and c) [ 14C]isoleucine by intact 
cells of 8. brevis (time of addition of the antibiotic is in- 
dicated by the arrow): C) control; A) avilamycin 0.7 fig/ml. 
Experimental conditions were identical to those described 
previously [ I 11. 
streptomycin increases poly U-directed incorporation 
of [ 14C]isoleucine. As shown in table 2, avilamycin 
did not promote mistakes in the translation of the 
genetic code like streptomycin does. 
The binding of [14C]phenylalanyl-tRNA to washed 
ribosomes directed by poly U was assayed employing 
the filter technique of Nirenberg and Leder [lo]. The 
results obtained indicated that 2.86 X lop5 M of 
avilamycin inhibits this reaction to the extent of 
approximately 50% (table 3). Higher antibiotic con- 
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Fig. 2. Effect of concentrations of avilamycin on the poly- 
peptide synthesis directed by poly U (A, B) or by the RNA 
of phage Qp (C) in the cell-free systems of B. brevis (A) and 
k’. coli (B. C). 
centrations did not result in a significant further 
increase of inhibition. The fact, that avilamycin in- 
hibited the binding of phenylalanyl-tRNA to ribo- 
somes by no more than about 50% suggested that this 
antibiotic blocked one of the two binding sites for 
aminoacyi-tRNA. 
A 
J 1 I 1 I 1 1 1 1 
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Fig. 4. Effect of concentrations of high-speed supernatant 
(S-l 00) and ribosomes (70 S) on the extent of inhibition of 
the poly U-directed polyphenylalanine synthesis (E. coli) by 
avilaniycin 0.1 fig/50 ~1. 
In other experiments the effect of avilamycin on 
the AUG-directed enzymatic binding of formyl- I3 H] - 
methionyl-tRNA to the 30 S ribosomal subunits was 
tested. We have observed a complete inhibition of the 
reaction by the antibiotic (table 4). 
Studies were continued to localize the binding site 
of the antibiotic. As shown in fig. 4, the inhibitory 
$ 
1 
0.3 - 
Fig. 3. Effect of avilamycin on the attachment of [3H]poly U to ribosomes (E. COW: A) control; B) avilamycin 50 pg/250 ~1 
Experimental conditions were identical to those described [ 121. 
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Table 3 
Effect of avilamycin on the binding of [ “C]phenylalanyl- 
tRNA to ribosomes (I?. coli). 
Antibiotic added 
(M) 
[ 14C]phenylalanyl- 
tRNA bound to 
ribosomes 
(cpm) (%) 
Control 
Avilamycin 
2.86 x lo-* 
2.86 X lO-7 
2.86 x lO-‘j 
2.86 x lo-’ 
2.86 x 1O-4 
Tetracycline 
8.3 x 1O-6 
8.3 x 1O-5 
8.3 x 1O-4 
1 256 100 
945 75 
874 70 
630 50 
786 63 
626 50 
846 67 
638 51 
742 59 
effect of avilamycin was noticeably decreased by the 
addition of excess of ribosomes (70 S), but not by 
addition of supernatant enzymes (S-100 fraction). 
Further experiments were carried out with separated 
subunits of E. coli ribosomes. As shown in table 5, 
the combination of avilamycin-treated 30 S subunits 
and control 50 S subunits showed a much lower pep- 
tide synthesizing activity than that of treated 50 S 
subunits and control 30 S subunits. 
The data indicate that avilamycin binds with the 
30 S subunits of E. coli ribosomes and interferes with 
Table 4 
Effect of avilamycin on the binding of formyl-[ 3H] methionyl- 
tRNA to the 30 S ribosomal subunits directed by AUG 
(E. cob). 
Antibiotic added 
(M) 
Complete system 
- AUG 
Avilamycin 
1.43 x10-7 
1.43 x10-6 
1.43 x 10-s 
1.43 x 10-4 
Formyl-[ 3H]methionyl- 
tRNA bound to the 
30 S ribosomal subunits 
(cpm) (%) 
462 100 
80 0 
367 75 
143 16 
56 0 
88 2 
Table 5 
Effect of avilamycin-treated ribosomal subunits on the poly- 
phenylalanine synthesis in the cell-free system of E. co/i. 
Ribosomal Concentration 
subunits of avilamycin 
added** (M) 
Polyphenyl- 
alanine 
synthesized 
(cpm) (‘-/,) 
30s ~ _ 819 11 
3os* - _ 675 9 
_ 50 s _ I 431 20 
_ 50 s* _ 1 022 14 
30 s 50 s 7 314 100 
3os* 5os* _ 3 894 53 
30 s 50 s 1.43 x10-5 3 055 42 
30 s* 50 s 4 027 55 
30 s 50 s* _ 5 346 73 
** Ribosomal subunits preincubated in the absence (30 S, 
50 S) or presence (30 S*, 50 S*) of an excess of avilamycin 
(20 min at 30°C) and dialyzed at 4°C for 4 hr with 3 
changes of standard buffer. 
The samples contained the standard reaction mixture, how- 
ever 0.3 A260 units 30 S and 0.6 A260 units 50 S particles 
were added per assay according to the data in the table. 
the polypeptide-synthesizing function by affecting the 
attachment of aminoacyl-tRNA to the ribosomes. 
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